Multiple actinic keratosis and skin tumors secondary to hydroxyurea treatment.
Salmon-Ehr
V
V
Grosieux
C
C
Potron
G
G
Kalis
B
B
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000139:chemically induced; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects* / Q000627:therapeutic use; D007642:Keratosis / Q000139:chemically induced*; D008297:Male; D011087:Polycythemia Vera / Q000188:drug therapy; D012871:Skin Diseases / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000139:chemically induced*
D000970:Antineoplastic Agents; D002066:Busulfan; D006918:Hydroxyurea